BIOS
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
BIOS
Delisted
BIOS was delisted on the 6th of October, 2023.
65 hedge funds and large institutions have $190M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
65
Holding in Top 10
–
Calls
$101K
Puts
–
Top Buyers
| 1 | +$5.17M | |
| 2 | +$4.03M | |
| 3 | +$2.98M | |
| 4 |
SCM
Saba Capital Management
New York
|
+$2.52M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$2.27M |
Top Sellers
| 1 | -$2.5M | |
| 2 | -$2.47M | |
| 3 | -$2.4M | |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$1.46M |
| 5 |
FLC
Fifth Lane Capital
Austin,
Texas
|
-$1.01M |